Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat

Detalhes bibliográficos
Autor(a) principal: Fonseca, Andre V. [UNIFESP]
Data de Publicação: 2004
Outros Autores: Ferreira, Lydia Masako [UNIFESP], Gomes, Heitor C. [UNIFESP], Percário, Sandro [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S0102-86502004000300004
http://repositorio.unifesp.br/handle/11600/2113
Resumo: PURPOSE: To evaluate the effect of Terazosin and Propranolol on the prevention of necrosis induced by nicotine, in a random skin flap. METHODS: This study utilized 32 adult male Wistar-EPM rats divided, at random, into four groups of eight animals each. All the 32 animals received nicotine (2 mg/kg/day) subcutaneously, for one week before and one week after flap elevation. CG (Control) group received distilled water (0.2 ml/day) by gavage and saline (0.5 ml) intraperitoneally, for seven days in the postoperative period. TG (Terazosin) group received terazosin hydrochloride (3 mg/day) by gavage and saline, intraperitoneally, for seven days in the postoperative period. PG (Propranolol) group received propranolol (1.5 mg/day) intraperitoneally and distilled water, by gavage, following the stablished pattern. TPG (Terazosin + Propranolol) group received both drugs. On the seventh postoperative day, the distal necrotic area of the flaps was determined via the paper template method. Blood and skin samples were collected in order to allow determination of Malondialdehyde (MDA) levels RESULTS: The control group had a mean value of 39.5 % of necrosis; the Terazosin group 25.1 %; the Propranolol group 34.5 % and the Terazosin + Propranolol group 26.2 % of necrosis. MDA levels in the serum and in the skin samples behave similarly, with an exception regarding Propranolol group in this case. CONCLUSION: Terazosin is effective in the prevention of necrosis in this animal model and Propranolol is not effective in this case.
id UFSP_b12a2be0239093b73bf840db05741644
oai_identifier_str oai:repositorio.unifesp.br/:11600/2113
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the ratTerazosina e propanolol como bloqueadores do efeito deletério da nicotina em um retalho cutâneo randômico, no ratoSurgical flapsNicotineLipid peroxidationTerazosinPropranololRatsRetalhos cirúrgicosNicotinaPeroxidação lipídicaTerazosinaPropranololRatosPURPOSE: To evaluate the effect of Terazosin and Propranolol on the prevention of necrosis induced by nicotine, in a random skin flap. METHODS: This study utilized 32 adult male Wistar-EPM rats divided, at random, into four groups of eight animals each. All the 32 animals received nicotine (2 mg/kg/day) subcutaneously, for one week before and one week after flap elevation. CG (Control) group received distilled water (0.2 ml/day) by gavage and saline (0.5 ml) intraperitoneally, for seven days in the postoperative period. TG (Terazosin) group received terazosin hydrochloride (3 mg/day) by gavage and saline, intraperitoneally, for seven days in the postoperative period. PG (Propranolol) group received propranolol (1.5 mg/day) intraperitoneally and distilled water, by gavage, following the stablished pattern. TPG (Terazosin + Propranolol) group received both drugs. On the seventh postoperative day, the distal necrotic area of the flaps was determined via the paper template method. Blood and skin samples were collected in order to allow determination of Malondialdehyde (MDA) levels RESULTS: The control group had a mean value of 39.5 % of necrosis; the Terazosin group 25.1 %; the Propranolol group 34.5 % and the Terazosin + Propranolol group 26.2 % of necrosis. MDA levels in the serum and in the skin samples behave similarly, with an exception regarding Propranolol group in this case. CONCLUSION: Terazosin is effective in the prevention of necrosis in this animal model and Propranolol is not effective in this case.OBJETIVO: O objetivo deste estudo experimental foi avaliar o efeito da Terazosina e do Propranolol na prevenção da necrose induzida pela nicotina, em um retalho cutâneo randômico. MÉTODOS: Este estudo utilizou 32 ratos machos adultos Wistar-EPM divididos, ao acaso, em quatro grupos de oito animais. Todos os 32 animais receberam nicotina (2 mg/kg/dia), por via subcutânea, por uma semana antes e uma semana após a elevação do retalho. O grupo CG (Controle) recebeu água destilada (0,2 ml/dia), por gavagem e salina (0,5 ml), por via intraperitoneal, por sete dias no período pós-operatório. O grupo TG (Terazosina) recebeu terazosina (3 mg/dia), por gavagem, e salina, intraperitoneal, por sete dias no pós-operatório. O grupo PG (Propranolol) recebeu propranolol (1,5 mg/dia), intraperitoneal e água destilada, por gavagem, seguindo o padrão estabelecido. O grupo TPG (Terazosina + Propranolol) recebeu ambas as drogas. No sétimo dia de pós-operatório, a área de necrose distal dos retalhos foi determinada pelo método do gabarito de papel. Amostras de sangue e de pele foram coletadas de forma a permitir a determinação dos níveis de malondialdeído (MDA). RESULTADOS: O grupo controle apresentou um valor médio de necrose de 39,5 %; o grupo Terazosina 25,1 %; o grupo Propranolol 34,5 % e o grupo Terazosina + Propranolol 26,2 % de necrose. Os níveis de MDA no soro e nas amostras de pele comportaram-se de maneira similar, com uma exceção no caso do grupo Propranolol neste caso. CONCLUSÃO: A Terazosina foi eficaz na prevenção da necrose neste modelo animal e o Propranolol não foi eficaz neste caso.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Plastic Surgery DivisionUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Vascular Surgery DivisionUNIFESP, EPM, Plastic Surgery DivisionUNIFESP, EPM, Vascular Surgery DivisionSciELOSociedade Brasileira para o Desenvolvimento da Pesquisa em CirurgiaUniversidade Federal de São Paulo (UNIFESP)Fonseca, Andre V. [UNIFESP]Ferreira, Lydia Masako [UNIFESP]Gomes, Heitor C. [UNIFESP]Percário, Sandro [UNIFESP]2015-06-14T13:31:08Z2015-06-14T13:31:08Z2004-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion186-195application/pdfhttp://dx.doi.org/10.1590/S0102-86502004000300004Acta Cirurgica Brasileira. Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia, v. 19, n. 3, p. 186-195, 2004.10.1590/S0102-86502004000300004S0102-86502004000300004.pdf0102-8650S0102-86502004000300004http://repositorio.unifesp.br/handle/11600/2113engActa Cirurgica Brasileirainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-04T12:13:46Zoai:repositorio.unifesp.br/:11600/2113Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-04T12:13:46Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
Terazosina e propanolol como bloqueadores do efeito deletério da nicotina em um retalho cutâneo randômico, no rato
title Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
spellingShingle Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
Fonseca, Andre V. [UNIFESP]
Surgical flaps
Nicotine
Lipid peroxidation
Terazosin
Propranolol
Rats
Retalhos cirúrgicos
Nicotina
Peroxidação lipídica
Terazosina
Propranolol
Ratos
title_short Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
title_full Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
title_fullStr Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
title_full_unstemmed Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
title_sort Terazosin and propranolol as blockers to the deleterious effect of nicotine in a random skin flap, in the rat
author Fonseca, Andre V. [UNIFESP]
author_facet Fonseca, Andre V. [UNIFESP]
Ferreira, Lydia Masako [UNIFESP]
Gomes, Heitor C. [UNIFESP]
Percário, Sandro [UNIFESP]
author_role author
author2 Ferreira, Lydia Masako [UNIFESP]
Gomes, Heitor C. [UNIFESP]
Percário, Sandro [UNIFESP]
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Fonseca, Andre V. [UNIFESP]
Ferreira, Lydia Masako [UNIFESP]
Gomes, Heitor C. [UNIFESP]
Percário, Sandro [UNIFESP]
dc.subject.por.fl_str_mv Surgical flaps
Nicotine
Lipid peroxidation
Terazosin
Propranolol
Rats
Retalhos cirúrgicos
Nicotina
Peroxidação lipídica
Terazosina
Propranolol
Ratos
topic Surgical flaps
Nicotine
Lipid peroxidation
Terazosin
Propranolol
Rats
Retalhos cirúrgicos
Nicotina
Peroxidação lipídica
Terazosina
Propranolol
Ratos
description PURPOSE: To evaluate the effect of Terazosin and Propranolol on the prevention of necrosis induced by nicotine, in a random skin flap. METHODS: This study utilized 32 adult male Wistar-EPM rats divided, at random, into four groups of eight animals each. All the 32 animals received nicotine (2 mg/kg/day) subcutaneously, for one week before and one week after flap elevation. CG (Control) group received distilled water (0.2 ml/day) by gavage and saline (0.5 ml) intraperitoneally, for seven days in the postoperative period. TG (Terazosin) group received terazosin hydrochloride (3 mg/day) by gavage and saline, intraperitoneally, for seven days in the postoperative period. PG (Propranolol) group received propranolol (1.5 mg/day) intraperitoneally and distilled water, by gavage, following the stablished pattern. TPG (Terazosin + Propranolol) group received both drugs. On the seventh postoperative day, the distal necrotic area of the flaps was determined via the paper template method. Blood and skin samples were collected in order to allow determination of Malondialdehyde (MDA) levels RESULTS: The control group had a mean value of 39.5 % of necrosis; the Terazosin group 25.1 %; the Propranolol group 34.5 % and the Terazosin + Propranolol group 26.2 % of necrosis. MDA levels in the serum and in the skin samples behave similarly, with an exception regarding Propranolol group in this case. CONCLUSION: Terazosin is effective in the prevention of necrosis in this animal model and Propranolol is not effective in this case.
publishDate 2004
dc.date.none.fl_str_mv 2004-06-01
2015-06-14T13:31:08Z
2015-06-14T13:31:08Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S0102-86502004000300004
Acta Cirurgica Brasileira. Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia, v. 19, n. 3, p. 186-195, 2004.
10.1590/S0102-86502004000300004
S0102-86502004000300004.pdf
0102-8650
S0102-86502004000300004
http://repositorio.unifesp.br/handle/11600/2113
url http://dx.doi.org/10.1590/S0102-86502004000300004
http://repositorio.unifesp.br/handle/11600/2113
identifier_str_mv Acta Cirurgica Brasileira. Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia, v. 19, n. 3, p. 186-195, 2004.
10.1590/S0102-86502004000300004
S0102-86502004000300004.pdf
0102-8650
S0102-86502004000300004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Acta Cirurgica Brasileira
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 186-195
application/pdf
dc.publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
publisher.none.fl_str_mv Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268304256139264